Events

Webinar: Addressing IP impact and innovation in EU projects
NOV
Thu
27
10:30 - 12:00

This was 4 months ago

Location

Online

Programmes
Horizon Europe

The European IP Helpdesk is organising a webinar on different ways to define professional and systematic IP management in Horizon Europe projects. It requires an advanced level of expertise.

Learning objectives:

  • Impact and  innovation in HEU project proposals
  • Exploitation of project results
  • Business landscape in project proposals
  • Researchers' rights on project results
  • IPR protection for project results
  • State of the art, prior art definition - patent databases (e.g. Espacenet)
  • Support and sources of information on IPR 

You can find more information here and register here

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.